| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |